Quarter in review: Clinical Science
Kavya Devi Nunna MD (General Medicine), DM (Rheumatology)Consultant RheumatologistAnvitha Arthritis Centre, Vijayawada, Andhra Pradesh, India Study in focus 1: Low uveitis rates in patients with axial spondyloarthritis treated with Bimekizumab: pooled results from phase 2b/3 trials. Both tumour necrosis factor-alpha (TNF-α) and interleukin (IL)-17 are potential targets for uveitis in axial spondylarthritis (axSpA). With the conflicting […]
Quarter in Review: Basic Science
Sreejitha KS MBBS, MD, DM (Clinical Immunology & Rheumatology)Consultant Rheumatologist, Manipal Hospital, Old Airport Road, Bangalore, India Study in focus 1: EphB2 Receptor Promotes Dermal Fibrosis in Systemic Sclerosis Systemic sclerosis (SSc) is characterized by skin and organ fibrosis from excessive extracellular matrix deposition by fibroblasts. Erythropoietin-producing hepatocellular(Eph) receptor tyrosine kinases- Eph A and Eph B- […]
Lupus support group India
Ms. Vachasmrita Co-founder of Lupus Trust India What prompted you to start this group? Diagnosed with aggressive lupus at 13, I believed I was the only Indian with the condition until I met others through my treating rheumatologist. Witnessing the severe struggles of a patient from an economically weaker background deeply pained me. This led […]
Social media in Rheumatology
Kunal Chandwar MD, DMConsultant Rheumatologist, Zydus Hospital, Ahmedabad@ERheumat @kunalchandwar How did you get the idea to start an online educational platform (on X)? The idea to start an online educational platform on X (formerly Twitter) for rheumatology came during the COVID-19 pandemic. X’s real-time updates highlighted its potential for rapid medical knowledge dissemination. This inspired […]
Challenges to access and care For Lupus Patients – Global Perspective
Laurent Arnaud MD, PhDProfessor of Medicine, Department of Rheumatology, French National Reference Center for Autoimmune Diseases (RESO), Academic Hospitals of Strasbourg, Strasbourg, FranceTwitter: @Lupusreference First of all, I would like to say that with increasing globalization, the issue of access to care has taken on major importance in recent years. This is also true because […]
Difficult to treat Lupus nephritis
Molly Mary Thabah MD Medicine Professor and HeadClinical Immunology & Rheumatology, JIPMER Puducherry, India What is Difficult to treat lupus nephritis The current standard of care for induction of remission in lupus nephritis (LN) is glucocorticoids and immunosuppression (IST) with either intravenous (IV) cyclophosphamide (CYC) or oral mycophenolate mofetil (MMF). A complete response to treatment […]
Challenges to access and care For Lupus Patients – Indian Perspective
Liza Rajasekhar MD (Internal Medicine), Fellowship in Clinical RheumatologyProfessor and Head, Department of Clinical Immunology and Rheumatology, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India What do you think are the main challenges? The most important challenge is the gaps in the public health care system of the country. The largest numbers of patients come […]
Emerging treatment options for lupus
Devarasetti Phani Kumar MD (Internal medicine), DM (Rheumatology)Associate Professor, Department of Clinical Immunology and RheumatologyNizam’s Institute of Medical Sciences, Hyderabad, Telangana, India Treatment of lupus is moving from non-specific or global immunosuppression to targeted therapies. In this review, recently approved drugs, and emerging therapies showing promise in early trials were reviewed Newly approved drugs for […]
Immunopathogenesis of lupus
Ranjan Gupta MD (Internal Medicine), DM (Clinical Immunology)Additional Professor, Dept. of Rheumatology, AIIMS, New Delhi Systemic Lupus Erythematosus (SLE) is a prototypic autoimmune disease affecting any organ system. It most commonly affects the young ladies in the reproductive age group. Our understanding of its pathogenesis has improved considerably which has made translational advances in its […]
Milestones in the history of lupus
Kavita Krishna MD, DNB, Post-doc Fellowship in Rheumatology, EULAR(cert), GSMC-FAIMER Professor & Head, Department of Clinical Immunology & RheumatologyBharati Vidyapeeth University Medical College & Hospital, Pune, India The history of lupus can be divided into three periods: classical, neoclassical, and modern Earlier classical descriptions of the skin lesions and the origin of the name “lupus” […]
